Point-of-Care Ultrasound Is a Valuable Modality During Mass COVID-19 Vaccination Campaigns.
Wang-Sheng LinDavid KilleenChen-Ya YangPublished in: Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine (2021)
Coronavirus disease 2019 has become a widespread public health crisis across the globe, requiring multiple approaches to containment, treatment, and prevention. Vaccines are an important tool to prevent morbidity and mortality from this devastating virus. Ensuring direct administration of vaccines into target tissue helps provide an optimal immune response while decreasing unintended adverse effects. Point-of-care ultrasound can better assist clinicians to determine appropriate needle length and penetration level especially in special populations. Examples include patients who are obese, pregnant, or with refractory lymphedema, and those living in areas where needle supply is unstable or insufficient.
Keyphrases
- coronavirus disease
- public health
- ultrasound guided
- immune response
- end stage renal disease
- magnetic resonance imaging
- chronic kidney disease
- ejection fraction
- sars cov
- metabolic syndrome
- adipose tissue
- type diabetes
- respiratory syndrome coronavirus
- weight loss
- peritoneal dialysis
- pregnant women
- patient reported outcomes
- inflammatory response